Skip to main content
Equibles
LQDA logo

LQDA · Liquidia Corp · Metrics

Track LQDA — free

Use LQDA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research LQDA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$35.93 +1.80 (+5.27%)
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$3.05B
Shares
89.51M
Volume · Oct 20 1.83M Avg daily vol (3M) 3.1M

LQDA metrics

89 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$34.13
Market cap
$3.05B

Price action

20 metrics
Price change (1W)
+23.3%
Price change (30D)
-48.6%
Price change (3M)
-55.7%
Price change (6M)
-9.4%
Price change (YTD)
-1.0%
Price change (1Y)
+51.8%
Trailing year
Price change (5Y)
+877.9%
52-week high
$91.03
52-week low
$22.02
Change from 52-week high
-62.5%
Change from 52-week low
+55.0%
Annualized volatility
91.7%
Annualized volatility (3M)
138.1%
Beta
0.7
RSI (14D)
35.3
Price vs SMA 50
-42.5%
Price vs SMA 200
-36.7%
Avg volume (3M)
3.10M
Relative volume
1.0
Average dollar volume
$143.40M

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
89.51M

Valuation

12 metrics
P / E (TTM)
24.4
Trailing earnings · reciprocal yield 4.1%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
6.8×
reciprocal yield 14.7%
P / book
15.8
reciprocal yield 6.3%
FCF yield
4.9%
TTM · current market cap
Buyback yield
—
P / FCF
20.4
reciprocal yield 4.9%
P / operating cash flow
18.3
reciprocal yield 5.5%
Earnings yield
4.5%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
20.5×
reciprocal yield 4.9%
EV / revenue historical average (5Y)
20.5×
reciprocal yield 4.9%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-12

Profitability

9 metrics
Gross margin
—
Operating margin
37.4%
Trailing 12 months
Net margin
30.7%
Gross profit (TTM)
$8.21M
Operating profit (TTM)
$168.57M
Net income (TTM)
$138.61M
Trailing 12 months
Diluted EPS (TTM)
$1.40
FCF margin
33.4%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$4.69
Gross profit per diluted share (TTM)
$0.10
Operating profit per diluted share (TTM)
$1.70
EBITDA per diluted share (TTM)
$1.72
Net income per diluted share (TTM)
$1.39
Operating cash flow per diluted share (TTM)
$1.71
Free cash flow per diluted share (TTM)
$1.54
Capital expenditures per diluted share (TTM)
$0.17
R&D per diluted share (TTM)
$0.60
Stock compensation per diluted share (TTM)
$0.37
Book value per share
$0.51

Growth

11 metrics
Revenue growth YoY
+1,842.7%
Year over year
Net income growth YoY
—
Revenue (TTM)
$450.91M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+18.5%
Year over year · more shares
Revenue CAGR (3Y)
+115.0%
Revenue CAGR (5Y)
+192.5%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
71.0%
Return on assets
26.6%
Debt / equity
—
Current ratio
2.3
EBITDA (TTM)
$170.25M
Free cash flow (TTM)
$150.69M
Quick ratio
2.1
Interest coverage
6.3
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$284.18M
Total assets
$521.92M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$167.71M
Capital expenditures (TTM)
$17.01M
R&D (TTM)
$56.04M
SG&A (TTM)
$192.66M
Stock compensation (TTM)
$34.69M
R&D / revenue
12.4%
Stock compensation / revenue
7.7%

Ownership (13F)

9 metrics
13F filers
342
13F filer change QoQ
+91
Institutional ownership
89.3%
Conviction holders (share of 13F filers)
1.1%
Crowding (high-turnover and private-fund holders)
25.5%
Private-fund adviser ownership
25.0%
Active holders' share change QoQ
-0.6%
Holder tenure
6.9
Price vs estimated holder cost
+27.6%

Ownership (registered funds)

1 metrics
Index-fund ownership
19.3%

Short interest

3 metrics
Short interest
14.1%
Latest settlement · 3.8 days to cover
Days to cover
3.8d
Short-squeeze score
69 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$43.65M
Insider-sentiment score
8 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1819576 CUSIP 53635D202 13F (30d) 23 filings 23 filers Visit website Investor relations